Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BY-NC-NDCPT: pharmacometrics & systems pharmacology

Preclinical Pharmacokinetic‐Pharmacodynamic Modeling of Antibody Nanoconjugates for Breast Cancer Treatment

  • Anne Rodallec1
  • Cristina Vaghi2
  • Joseph Ciccolini1
  • Raphaelle Fanciullino1
  • Sebastien Benzekry1
  1. 1Centre Inria D'université Côte D'azur, Aix Marseille Univ, CNRS, INSERM, Institut Paoli‐Calmettes, CRCM
  2. 2Centre Inria de L'université de Bordeaux
Read full textPDFCite

Related

  1. Prior-informed population pharmacokinetic-pharmacodynamic modeling of dexamethasone in horses
    Ruihong Yu, Pierre-Louis Toutain, Carl Ekstrand +1
    Journal of Pharmacokinetics and PharmacodynamicsPeer-reviewedCC BY 4.0Full textGeneral biologyHAL
  2. Accelerating drug development in infectious diseases using zebrafish disease models supported by pharmacokinetic pharmacodynamic modeling as new approach methodology (NAM)
    G. Forn-Cuni, B. van Lieshout, B. Koch +11
    bioRxivPreprintCC BYFull text1 citedPharmacology & toxicologybioRxiv
  3. Pharmacokinetic and pharmacodynamic strategies to optimize antifungal therapy, prevent resistance and minimize treatment failure
    Norman Van Rhijn, P Lewis White, Riina Rautemaa-Richardson
    JAC-Antimicrobial ResistancePeer-reviewedCC BY 4.0Full textInfectious diseasePMC
  4. Risk of extrapyramidal side effects in the newborn after single dose maternal metoclopramide administration prior to cesarean section: an analysis via physiology-based pharmacokinetic and pharmacodynamic modeling
    H. van Hove, J. E. M. van der Heijden, P. van den Broek +3
    medRxivPreprintCC BY-NC-NDFull textPharmacology & toxicologymedRxiv
  5. Microbiota–Gut–Brain Axis Interactions with CNS Drugs: A Critical Mechanistic Review of Biopharmaceutical, Pharmacokinetic, and Pharmacodynamic Evidence
    PharmaceuticsPeer-reviewedCC BYFull textEurope PMC

Cite

BibTeXRIS
BibTeX
@article{rodallec2026preclinical,
  title = {{Preclinical Pharmacokinetic‐Pharmacodynamic Modeling of Antibody Nanoconjugates for Breast Cancer Treatment}},
  author = {Anne Rodallec and Cristina Vaghi and Joseph Ciccolini and Raphaelle Fanciullino and Sebastien Benzekry},
  journal = {CPT: pharmacometrics \& systems pharmacology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655776},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Preclinical Pharmacokinetic‐Pharmacodynamic Modeling of Antibody Nanoconjugates for Breast Cancer Treatment
AU  - Anne Rodallec
AU  - Cristina Vaghi
AU  - Joseph Ciccolini
AU  - Raphaelle Fanciullino
AU  - Sebastien Benzekry
PY  - 2026
DA  - 2026/10/01
JO  - CPT: pharmacometrics & systems pharmacology
UR  - https://europepmc.org/article/PMC/PMC13655776
SN  - 2163-8306
ER  -